A splicing variant of the RON transcript induces constitutive tyrosine kinase activity and an invasive phenotype

Molecular and Cellular Biology

Volumn 16, Issue 10, 1996, Pages 5518-5526

  Collesi, Chiara ^a   Santoro, Massimo M ^a,b   Gaudino, Giovanni ^b   Comoglio, Paolo M ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b Dept Sci Adv Technol Alessandria ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE;

ARTICLE; CELL LINE; DNA SEQUENCE; DNA TRANSCRIPTION; EXON; EXTRACELLULAR MATRIX; GENETIC TRANSFECTION; NORTHERN BLOTTING; OLIGOMERIZATION; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; SITE DIRECTED MUTAGENESIS; STOMACH CARCINOMA;

EID: 0029837671     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.16.10.5518     Document Type: Article

References (48)

1. Alberini, C. M., P. Bet, C. Milstein, and R. Sitia. 1990. Secretion of immunoglobulin M assembly intermediates in the presence of reducing agents. Nature (London) 347:485-487.
2. Albini, A., Y. Iwamoto, H. K. Kleinman, G. R. Martin, S. A. Aaronson, J. M. Kozlowski, and R. N. McEwan. 1987. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 47:3239-3245.
3. Andreadis, A., M. E. Gallengo, and B. Nadal-Ginard. 1987. Generation of protein isoform diversity by alternative splicing: mechanism and biological implications. Annu. Rev. Cell Biol. 3:207-242.
4. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1987. Current protocols in molecular biology. John Wiley & Sons, New York.
5. Bargmann, C. I., M. C. Hung, and R. A. Weinberg. 1986. Multiple independent activations of the neu oncogene by point mutations altering the transmembrane domain of p185. Cell 45:649-657.
6. Breitbart, R. E., A. Andreadis, and B. Nadal-Ginard. 1987. Alternative splicing: a ubiquitous mechanism for the generation of multiple protein isoforms from single genes. Annu. Rev. Biochem. 56:467-495.
7. Chomczynski, P., and N. Sacchi. 1987. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
8. Comoglio, P. M., and C. Boccaccio. The hgf receptor family: unconventional signal transducers for invasive cell growth. Genes Cells, in press.
9. Cooper, C. S., M. Park, D. Blair, M. A. Tainsky, K. Huebner, C. M. Croce, and G. F. Vande Woude. 1984. Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature (London) 311:29-33.
10. Coulier, F., R. Kumar, M. Ernst, R. Klein, D. Martin Zanca, and M. Barbacid. 1990. Human trk oncogene activated by point mutation, in-frame deletion, and duplication of the tyrosine kinase domain. Mol. Cell. Biol. 10:4202-4210.
11. Don, R. H., P. T. Cox, B. J. Wainwright, K. Baker, and J. S. Mattick. 1991. "Touchdown" PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res. 19:4008-4017.
12. Downword, J., Y. Yarden, E. Mayes, G. Scrace, N. Totty, P. Stockwell, A. Ullrich, J. Schlessinger, and M. D. Waterfield. 1984. Close similarity of epidermal growth factor receptor and v-erbB oncogene protein sequences. Nature (London) 307:521-527.
13. Gaudino, G., A. Follenzi, L. Naldini, C. Collesi, M. Santoro, K. A. Gallo, P. J. Godowski, and P. M. Comoglio. 1994. RON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP. EMBO J. 13:3524-3532.
14. Giordano, S., M. F. Di Renzo, R. Narsimhan, C. S. Cooper, C. Rosa, and P. M. Comoglio. 1989. Biosynthesis of the protein encoded by the c-met protooncogene. Oncogene 4:1383-1388.
15. Giordano, S., C. Ponzetto, M. F. Di Renzo, C. S. Cooper, and P. M. Comoglio. 1989. Tyrosine kinase receptor indistinguishable from the c-met protein. Nature (London) 339:155-156.
16. Huff, J. L., M. A. Jelinek, C. A. Borgman, T. J. Lansing, and T. J. Parsons. 1993. The protooncogene c-sea encodes a transmembrane protein-tyrosine kinase related to the Met/hepatocyte growth factor/scatter factor receptor. Proc. Natl. Acad. Sci. USA 90:6140-6144.
17. Humphrey, M. B., J. Bryan, T. A. Cooper, and S. M. Berget. 1995. A 32-nucleotide exon-splicing enhancer regulates usage of competing 5′ splice sites in a differential internal exon. Mol. Cell. Biol. 15:3979-3988.
18. Hurtley, S. M., and A. Helenius. 1989. Protein oligomerization in the endoplasmic reticulum. Annu. Rev. Cell Biol. 5:277-307.
19. Itoh, H., V. Hattori, H. Sakamoto, H. Ishii, T. Kishi, H. Saski, T. Yoshida, M. Koono, T. Sugimura, and M. Terada. 1994. Preferential alternative splicing in cancer generates a K-sam messanger RNA with higher transforming activity. Cancer Res. 54:3237-3241.
20. Klausner, R. D., and R. Sitia. 1990. Protein degradation in the endoplasmic reticulum. Cell 62:611-614.
21. Kobayashi, H., O. Hidekazu, M. Sugimura, H. Shinohara, T. Fuju, and T. Terao. 1992. Inhibition of in vitro ovarian cancer cell invasion by modulation of urokinase-type plasminogen activator and cathepsin B. Cancer Res. 52: 3610-3614.
22. Lee, C., and K. M. Yamada. 1994. Alternatively spliced juxtamembrane domain of a tyrosine kinase receptor is a multifunctional regulatory site. J. Biol. Chem. 270:507-510.
23. 1234-1235 are critical for activation of the tyrosine kinase encoded by the MET proto-oncogene (HGF receptor). Oncogene 9:49-57.
24. Martin-Zanca, D., R. Oskam, G. Mitra, T. Copeland, and M. Barbacid. 1989. Molecular and biochemical characterization of the human TRK protooncogene. Mol. Cell. Biol. 9:24-33.
25. Medico, E., A. Mongiovi, J. Huff, M. A. Jelinek, A. Follenzi, G. Gaudino, J. T. Parsons, and P. M. Comoglio. 1996. The tyrosine kinase receptors ron and sea control "scattering" and morphogenesis of liver progenitor cells in vitro. Mol. Biol. Cell 7:495-504.
26. Mondino, A., S. Giordano, and P. M. Comoglio. 1991. Defective posttranslational processing activates the tyrosine kinase encoded by the MET protooncogene (hepatocyte growth factor receptor). Mol. Cell. Biol. 11:6084-6092.
27. Neilson, K. M., and R. E. Friesel. 1995. Constitutive activation of fibroblast growth factor receptor-2 by a point mutation associated with Crouzon syndrome. J. Biol. Chem. 270:26037-26040.
28. Nelson, K. K., and M. R. Green. 1988. Splice site selection and ribonucleoprotein complex assembly during in vitro pre-mRNA splicing. Genes Dev. 2:319-329.
29. Oda, T., Y. Kanai, K. Yoshiura, Y. Shimoyama, W. Birchmeier, T. Sugimura, and S. Hirohashi. 1994. E-cadherin gene mutations in human gastric carcinoma cell lines. Proc. Natl. Acad. Sci. USA 91:1858-1862.
30. Park, M., M. Dean, K. Kaul, M. J. Braun, M. A. Gonda, and G. F. Vande Woude. 1987. Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors. Proc. Natl. Acad. Sci. USA 84:6379-6383.
31. Pelham, H. R. B. 1989. Control of protein exit from the endoplasmic reticulum. Annu. Rev. Cell Biol. 5:1-23.
32. Ponzetto, C., A. Bardelli, Z. Zhen, F. Maina, P. Dalla Zonca, S. Giordano, A. Graziani, G. Panayotou, and P. M. Comoglio. 1994. A multifunctional docking site mediates signalling and transformation by hepatocyte growth factor/ scatter factor (HGF/SF) receptor family. Cell 77:1-20.
33. Qiu, F., P. Ray, K. Brown, P. E. Barker, S. Jhanwar, F. H. Ruddle, and P. Besmer. 1988. Primary structure of c-kit: relationship with the CSF/PDGF receptor tyrosine kinase family-oncogenic activation of v-kit involves deletion of extracellular domain and C-terminus. EMBO J. 7:1003-1011.
34. Reddy, P., A. Sparvoli, C. Fagioli, G. Fassina, and R. Sitia. 1996. Formation of reversible disulfide bonds with the protein matrix of the endoplasmic reticulum correlates with the retention of unassembled Ig-light chains. EMBO J. 15:2077-2085.
35. Rodriguez, G. A., M. A. Naujokas, and M. Park. 1991. Alternative splicing generates isoforms of the met receptor tyrosine kinase which undergo differential processing. Mol. Cell. Biol. 11:2962-2970.
36. Ronsin, C., F. Muscatelli, M. G. Mattei, and R. Breathnach. 1993. A novel putative tyrosine kinase of the Met family. Oncogene 8:1195-1202.
37. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
38. Santoro, M., F. Carlomagno, A. Romano, D. P. Bottaro, N. A. Dathan, M. Grieco, A. Fusco, G. Vecchio, B. Matoskova, M. H. Kraus, and P. P. Di Fiore. 1995. Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science 267:381-383.
39. Siegel, P. M., D. L. Dankort, W. R. Hardy, and W. J. Muller. 1994. Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors. Mol. Cell. Biol. 14:7068-7077.
40. Sorokin, A., M. A. Lemmon, A. Ullrich, and J. Schlessinger. 1994. Stabilization of an active dimeric form of the epidermal growth factor receptor by introduction of an inter-receptor disulfide bond. J. Biol. Chem. 269:9752-9759.
41. Takahashi, M., and G. M. Cooper. 1987. ret transforming gene encodes a fusion protein homologous to tyrosine kinases. Mol. Cell. Biol. 7:1378-1385.
42. Tanaka, K., A. Watakabe, and Y. Shimura. 1994. Polypurine sequences within a downstream exon function as a splicing enhancer. Mol. Cell. Biol. 14:1347-1354.
43. Terranova, V. P., E. S. Hujanen, D. M. Loeb, G. R. Martin, L. Thornburg, and V. Glushko. 1986. Use of a reconstituted basement membrane to measure cell invasiveness and select for highly invasive tumor cells. Proc. Natl. Acad. Sci. USA 83:465-469.
44. Terranova, V. P., E. S. Hujanen, and G. R. Martin. 1986. Basement membrane and the invasive activity of metastatic tumor cells. J. Natl. Cancer Inst. 77:311-316.
45. Wahl, G., M. Stern, and R. Stark. Efficient transfer of large DNA fragments from agarose gels to diazobenzyloxy-methyl-paper and rapid hybridization by using dextran sulfate. Proc. Natl. Acad. Sci. USA 58:7001-7005.
46. Watowich, S. S., A. Yoshimura, G. D. Longmore, D. J. Hilton, Y. Yoshimura. and H. F. Lodish. 1992. Homodimerization and constitutive activation of the erythropoietin receptor. Proc. Natl. Acad. Sci. USA 89:2140-2144.
47. Woolford, J. W., A. McAuliffe, and L. R. Rohrschneider. 1988. Activation of the feline c-fms proto-oncogene: multiple alterations are required to generate a fully transformed phenotype. Cell 55:965-977.
48. Xu, R., J. Teng, and T. A. Cooper. 1993. The cardiac troponin T alternative exon contains a novel purine-rich positive splicing element. Mol. Cell. Biol. 13:3660-3674.